Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The compound 4c showed strong potential as an anticancer agent.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Promising cancer treatments were found, but the manufacturer closed.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

The treatment is safe and shows promise for metastatic breast cancer.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The committee decided not to approve the drug due to low effectiveness and high risks.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

MVP treatment is effective and safe for recurrent breast cancer.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.